Authors
Benjamin Levine Ebert, MD, PhD, George P. Canellos, MD, and Jean S. Canellos professor of medicine at Harvard Medical School, chair of Medical Oncology at the Dana-Farber Cancer Institute, and a Howard Hughes Medical Institute investigator, Boston, Massachusetts.
Toufic Kachaamy is a gasterenterologist who has served as the chief of medicine at City of Hope Phoenix, in Phoenix, Arizona since 2016. Kachaamy is trained in advanced endoscopy, including endoscopic ultrasound, he helps care for patients fighting pancreatic, stomach, esophageal, colon, liver or bile duct cancer.
Ishwaria M. Subbiah, MD, MS, FASCO, is the executive director of Cancer Care Equity & Professional Wellness with Sarah Cannon Research Institute, and medical director of Supportive Care Oncology, Health Equity & Professional Well-being with The US Oncology Network.
Hong Tang, MD, FACP, is the chief medical officer of OnQuality Pharmaceuticals, LLC.
Genetics Laboratory Molecular Manager – Florida Cancer Specialists & Research Institute
David Valcárcel Ferreiras, MD, PhD, is the director, Hematopoietic Stem Cell Transplant Unit University Hospital Vall d'Hebron in Barcelona, Spain.
Rachel Grisham, MD is section head of Ovarian Cancer and Director of Gynecologic Medical Oncology, at Memorial Sloan Kettering Cancer Center. She is board certified by the American Board of Internal Medicine in Medical Oncology. Dr. Grisham’s research focuses on development of novel therapies and clinical trial design for treatment of recurrent ovarian cancer. She has a particular interest in the development of novel therapeutics for rare tumors, including low grade serous ovarian cancer and granulosa cell tumors. Dr. Grisham is a graduate of the ASCO Leadership Development Program and served as the chair the of Gynecologic Cancer Track of the 2021 ASCO Annual Scientific Meeting. Dr. Grisham has received an ASCO Merit Award, ASCO Conquer Cancer Foundation Career Development Award, Ovarian Cancer Research Fund Alliance Award, Kaleidoscope of Hope Grant, a Cycle for Survival Award, and a Translational and Integrative Medicine Research Fund Grant.
Santhosh Ambika, MD, is a hematologist-oncologist at Cancer Care Specialists in Reno, Nevada.